Author
Benjamin F. Miller
- Indexed works
- 13
- Total citations
- 984
- Active years
- 8
Collaborators
Works in the record
Aging Cell 2016
Open access · CC-BY
Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α‐glucosidase inhibitor or a Nrf2‐inducer
Aging Cell 2021
Open access · CC-BY
Necroptosis contributes to chronic inflammation and fibrosis in aging liver
Oxidative Medicine and Cellular Longevity 2015
Open access · CC-BY
Nrf2 Signaling and the Slowed Aging Phenotype: Evidence from Long-Lived Models
The Journals of Gerontology Series A 2013
Open access · OA
Assessment of Mitochondrial Biogenesis and mTORC1 Signaling During Chronic Rapamycin Feeding in Male and Female Mice
Aging Cell 2022
Open access · CC-BY
Lifespan benefits for the combination of rapamycin plus acarbose and for captopril in genetically heterogeneous mice
GeroScience 2019
Open access · OA
Taming expectations of metformin as a treatment to extend healthspan
The Journals of Gerontology Series A 2019
Open access · OA
Differential Effects of Rapamycin and Metformin in Combination With Rapamycin on Mechanisms of Proteostasis in Cultured Skeletal Myotubes
The Journal of Physiology 2023
Open access · CC-BY
Current limitations and future opportunities of tracer studies of muscle ageing
Scientific Reports 2023
Open access · CC-BY
Metabolic benefits of 17α-estradiol in liver are partially mediated by ERβ in male mice
The Journals of Gerontology Series A 2021
Preprint · OA
Antecedent Metabolic Health and Metformin (ANTHEM) Aging Study: Rationale and Study Design for a Randomized Controlled Trial
The Journals of Gerontology Series A 2023
Open access · CC-BY
A Genetically Heterogeneous Rat Model with Divergent Mitochondrial Genomes
Aging Cell 2024
Open access · CC-BY
Metformin treatment results in distinctive skeletal muscle mitochondrial remodeling in rats with different intrinsic aerobic capacities
bioRxiv (Cold Spring Harbor Laboratory) 2022
Preprint · CC-BY